Methods used for mock surveys for external quality control assessment for laboratory methods used for hepatitis viral antigen and antibody
| Year | Methods | Instruments, manufacturers |
|---|---|---|
| 2020-1st & 2nd trial | ECLIA | Cobas e801modules, Roche |
| CLIA | Architect i2000/Alinity i, Abbott | |
| Centaur XP/Atellica IM1600, Siemens Healthcare | ||
| UniCel DxI 800, Beckman Coulter | ||
| VITROS ECiQ, Ortho Clinical Diagnostics | ||
| Liaison XL, DiaSorin | ||
| FEIA | VIDAS, BioMérieux | |
| 2021-1st & 2nd trial | ECLIA | Cobas e801modules, Roche |
| CLIA | Alinity i, Abbott | |
| Atellica IM1600, Siemens Healthcare | ||
| FEIA | VIDAS, BioMérieux | |
| 2022-1st & 2nd trial | ECLIA | Cobas e801modules, Roche |
| CLIA | Architect i1000/Alinity i, Abbott | |
| Atellica IM1600, Siemens Healthcare | ||
| VITROS ECiQ, Ortho Clinical Diagnostics |
The following instruments were used: Cobas e 801 modules (Roche Diagnostics GmbH, Mannheim, Germany), Architect i1000/2000, Alinity i (Abbott Diagnostics, Abbott Park, IL, USA), Centaur XP, Atellica IM (Siemens Healthineers, Erlangen, Germany), UniCel DxI 800 (Beckman Coulter Inc., Brea, CA, USA), VITROS ECiQ (Ortho clinical Diagnostics, Raritan, NJ, USA), Liaison XL (DiaSorin, Saluggia, Italy), VIDAS (BioMérieux, Marcy-L'Etoile, France).
Abbreviations: ECLIA, electrochemiluminescence immunoassay; CLIA, chemiluminescence immunoassay; FEIA, fluorescence enzyme immunoassay.